From January 1, 2023 to March 31, 2023, the company has repurchased 445,000 shares, representing 0.08% for CNY 2.65 million. With this, the company has completed the repurchase of 7,643,500 shares, representing 1.36% for CNY 40.3 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.07 CNY | -2.31% | -3.80% | -17.29% |
1st Jan change | Capi. | |
---|---|---|
-17.29% | 400M | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.